To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene WIPF1andRNU7-44PTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
451 supporting clones for gene WIPF1andRNU7-44P back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX640870 human endometrium carcinoma cell line .a 1 to 3028 1 to 3028 N119D P198L tiling clone, available from DKFZ, AAA   3028/3028
(100 %)
4 diff
(99.9 %id)
DA264599 caudate nucleus .a 1978 to 2532 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
AK097901 thymus .a 1981 to 4223 1 to 2243   available from FLJ,   2243/2243
(100 %)
9 diff
(99.6 %id)
DB106519 thymus .a 1982 to 2545 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA884474   .a 1985 to 2467 2 to 484   capped   483/483
(100 %)
1 diff
(99.8 %id)
AA831729 germinal center B cell .a 1998 to 2295 309 to 12   AAA   298/298
(100 %)
1 diff
(99.7 %id)
TI_44170162   .a 2082 to 2909 75 to 904       830/904
(91 %)
25 diff
(97.3 %id)
BI553483 brain, hippocampus .a 2093 to 2909 1 to 819   available from MGC,   819/819
(100 %)
20 diff
(97.6 %id)
BC045584 Brain, hippocampus .a 2098 to 4223 1 to 2126   tiling clone, available from MGC, AAA   2126/2126
(100 %)
11 diff
(99.5 %id)
AA381542   .a 2182 to 2487 1 to 306       306/306
(100 %)
3 diff
(99.1 %id)
AA381793   .a 2182 to 2462 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
AA381817   .a 2182 to 2369 1 to 188       188/188
(100 %)
2 diff
(99.0 %id)
AA381920   .a 2182 to 2394 1 to 213       213/213
(100 %)
1 diff
(99.6 %id)
AA381983   .a 2182 to 2418 1 to 237       237/237
(100 %)
1 diff
(99.6 %id)
AA382014   .a 2182 to 2443 1 to 263       263/263
(100 %)
2 diff
(99.3 %id)
AA382041   .a 2182 to 2463 1 to 284       284/285
(99 %)
6 diff
(97.9 %id)
CD367015 Alveolar Macrophage, lung .a 2203 to 2915 728 to 17   AAA   712/712
(100 %)
3 diff
(99.6 %id)
BX506584 Liver .a 2321 to 3067 1 to 747       747/753
(99 %)
9 diff
(98.9 %id)
AA426506 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2360 to 2787 1 to 428       428/428
(100 %)
1 diff
(99.8 %id)
BU146100 dorsal root ganglia .a 2494 to 3377 1 to 894       894/964
(92 %)
22 diff
(97.8 %id)
BU177646 melanotic melanoma, skin .a 2506 to 3013 1 to 508   AAA   508/508
(100 %)
0 diff
(100 %id)
BP394893 pancreatic islet .a 2509 to 3016 1 to 508     Submitted on the opposite strand 508/510
(99 %)
1 diff
(99.9 %id)
AI005043 Kidney .a 2510 to 3013 524 to 21   AAA   504/504
(100 %)
0 diff
(100 %id)
BE551281 carcinoid, lung .a 2515 to 3031 520 to 4       517/520
(99 %)
0 diff
(100 %id)
AW086445 ovary, papillary serous carcinoma .a 2548 to 2976 439 to 11   AAA   429/429
(100 %)
0 diff
(100 %id)
AW268590 pooled .a 2550 to 3014 465 to 1       465/465
(100 %)
3 diff
(99.4 %id)
BF438588 brain, glioblastoma (pooled) .a 2550 to 3030 481 to 1       481/481
(100 %)
1 diff
(99.8 %id)
BF691183 melanotic melanoma, high MDR, skin .a 2572 to 3231 1 to 651       651/892
(72 %)
18 diff
(98.0 %id)
BG390127 embryonal carcinoma, cell line, testis .a 2573 to 3070 1 to 496       496/811
(61 %)
9 diff
(98.9 %id)
AI040258 senescent fibroblast .a 2578 to 3016 442 to 4       439/442
(99 %)
0 diff
(100 %id)
AA810975 germinal center B cell .a 2580 to 3023 448 to 5       444/448
(99 %)
0 diff
(100 %id)
AI889670 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2580 to 3013 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AW748731 breast .a 2599 to 3066 11 to 478       468/478
(97 %)
6 diff
(98.8 %id)
AI076854 brain, glioblastoma (pooled) .a 2600 to 3031 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
CA394010 eye, RPE/choroid .a 2609 to 3049 1 to 441       441/447
(98 %)
1 diff
(99.8 %id)
AA908192 carcinoid, lung .a 2657 to 3019 363 to 1       363/363
(100 %)
1 diff
(99.8 %id)
AI223956 lymph node, lymphoma, follicular mixed small and largecell .a 2657 to 3016 361 to 2       360/361
(99 %)
0 diff
(100 %id)
ES316019 melanoma cell line .a 2664 to 3083 457 to 38     Submitted on the opposite strand 420/542
(77 %)
0 diff
(100 %id)
BF969990 adrenal cortex carcinoma, cell line, adrenal gland .a 2685 to 3439 1 to 750       750/948
(79 %)
21 diff
(97.8 %id)
AI042511 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2689 to 3035 348 to 1       348/348
(100 %)
7 diff
(98.0 %id)
BF690761 melanotic melanoma, high MDR, skin .a 2833 to 3530 1 to 688       688/880
(78 %)
17 diff
(98.1 %id)
BF691412 melanotic melanoma, high MDR, skin .a 2839 to 3571 1 to 731       731/732
(99 %)
21 diff
(97.2 %id)
BM454546 embryonal carcinoma, cell line, testis .a 2840 to 3750 1 to 917       917/1059
(86 %)
18 diff
(98.4 %id)
AA294827 Pancreas .a 2845 to 3044 1 to 200       200/200
(100 %)
1 diff
(99.5 %id)
BU175474 embryonal carcinoma, cell line, testis .a 2860 to 3763 1 to 907       907/907
(100 %)
31 diff
(96.6 %id)
AW966771   .a 2867 to 3486 16 to 647       632/653
(96 %)
6 diff
(99.1 %id)
AA298303 uterus .a 2874 to 3070 1 to 197       197/197
(100 %)
3 diff
(98.5 %id)
BM691192 eye, RPE and Choroid .a 2897 to 3577 8 to 685       678/685
(98 %)
6 diff
(99.2 %id)
BG820214 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2903 to 3641 1 to 736   tiling clone,   736/736
(100 %)
7 diff
(99.1 %id)
BE891184 melanotic melanoma, skin .a 2904 to 3685 1 to 777       777/964
(80 %)
24 diff
(97.6 %id)
AW352088 head_neck .a 2916 to 3198 283 to 1   tiling clone,   283/283
(100 %)
0 diff
(100 %id)
CN284951 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2980 to 3451 1 to 472       472/472
(100 %)
2 diff
(99.6 %id)
FN097993 breast carcinoma .a 2997 to 3087 93 to 1     Submitted on the opposite strand 93/94
(98 %)
3 diff
(96.9 %id)
BG615701 embryonal carcinoma, testis .a 3002 to 3839 1 to 833       833/840
(99 %)
40 diff
(95.3 %id)
BM475558 embryonal carcinoma, cell line, testis .a 3046 to 3997 1 to 957   tiling clone,   957/1005
(95 %)
26 diff
(97.5 %id)
DV462507 cochlea, ear .a 3079 to 3461 1 to 383       383/383
(100 %)
5 diff
(98.7 %id)
FN121958 breast carcinoma .a 3086 to 3194 1 to 107       107/107
(100 %)
2 diff
(98.2 %id)
AA099600 uterus .a 3118 to 3377 1 to 264       264/266
(99 %)
6 diff
(97.8 %id)
BE172620 head_neck .a 3153 to 3415 1 to 264       264/264
(100 %)
3 diff
(98.9 %id)
BE673890 carcinoid, lung .a 3231 to 3740 1 to 510     Submitted on the opposite strand 510/510
(100 %)
1 diff
(99.9 %id)
BG149966 carcinoid, lung .a 3231 to 3622 1 to 392     Submitted on the opposite strand 392/392
(100 %)
1 diff
(99.8 %id)
BF110508 carcinoid, lung .a 3231 to 3714 1 to 484     Submitted on the opposite strand 484/484
(100 %)
3 diff
(99.4 %id)
AA866614   .a 3252 to 3421 1 to 160       160/170
(94 %)
17 diff
(90.0 %id)
TI_154133934   .a 3261 to 3673 515 to 97   AAA   419/1177
(35 %)
19 diff
(98.4 %id)
BM930816 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3275 to 3853 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
TI_151789404   .a 3275 to 4019 79 to 820       742/936
(79 %)
23 diff
(97.6 %id)
BE674059 carcinoid, lung .a 3291 to 3695 1 to 405     Submitted on the opposite strand 405/405
(100 %)
1 diff
(99.8 %id)
BM557453 melanotic melanoma, skin .a 3298 to 4221 33 to 967       935/1117
(83 %)
29 diff
(97.5 %id)
TI_154137056   .a 3340 to 4223 963 to 84   tiling clone, AAA   880/925
(95 %)
21 diff
(97.8 %id)
AV730615 hypothalamus .a 3341 to 3879 1 to 540       540/540
(100 %)
7 diff
(98.8 %id)
AI809674 pooled .a 3375 to 3854 480 to 1       480/480
(100 %)
5 diff
(99.0 %id)
AA290914 germinal center B cell .a 3455 to 3885 1 to 430   fully sequenced,   430/430
(100 %)
1 diff
(99.8 %id)
TI_154111231   .a 3463 to 4223 854 to 99   AAA   756/774
(97 %)
31 diff
(96.0 %id)
BX118781 placenta .a 3468 to 4187 31 to 750       720/750
(96 %)
6 diff
(99.2 %id)
R27041 placenta .a 3471 to 3795 18 to 355       338/380
(88 %)
15 diff
(96.1 %id)
AI570079 adenocarcinoma, Pancreas .a 3473 to 3809 356 to 20   AAA   337/337
(100 %)
2 diff
(99.5 %id)
FN055550 breast carcinoma .a 3474 to 3580 1 to 107       107/108
(99 %)
1 diff
(99.1 %id)
FN088207 breast carcinoma .a 3474 to 3582 1 to 107       107/107
(100 %)
2 diff
(98.2 %id)
R81298 placenta .a 3474 to 3905 1 to 436       436/447
(97 %)
17 diff
(96.2 %id)
TI_154134168   .a 3522 to 4223 814 to 104   AAA   711/1080
(65 %)
29 diff
(97.4 %id)
AA279159 germinal center B cell .a 3528 to 3858 331 to 1       331/331
(100 %)
0 diff
(100 %id)
BG390231 embryonal carcinoma, cell line, testis .a 3530 to 4224 1 to 691       691/922
(74 %)
9 diff
(99.1 %id)
BG025385 lymph, lymphoma, cell line .a 3531 to 4244 1 to 711   tiling clone,   711/821
(86 %)
13 diff
(98.5 %id)
TI_158431051   .a 3537 to 4223 791 to 105   AAA   687/890
(77 %)
19 diff
(97.9 %id)
FN086265 breast carcinoma .a 3539 to 3613 73 to 1     Submitted on the opposite strand 73/74
(98 %)
2 diff
(97.3 %id)
CB270821 adipose .a 3577 to 4083 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
BE006556 breast_normal .a 3583 to 3819 253 to 19     Submitted on the opposite strand 235/253
(92 %)
0 diff
(100 %id)
BM684666 eye, fetal eye .a 3592 to 4223 650 to 19   AAA   632/632
(100 %)
3 diff
(99.6 %id)
AW964574   .a 3624 to 4222 603 to 1     Submitted on the opposite strand 603/604
(99 %)
21 diff
(96.6 %id)
CB157775 Liver .a 3626 to 4216 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
AA247851   .a 3660 to 3772 1 to 113       113/114
(99 %)
2 diff
(98.3 %id)
CA448361 Chondrosarcoma, Left Pelvis .a 3669 to 4223 570 to 15   AAA   556/556
(100 %)
3 diff
(99.5 %id)
AI807929 pooled .a 3672 to 4223 566 to 14   AAA   553/553
(100 %)
8 diff
(98.6 %id)
AW058622 pooled .a 3673 to 4224 557 to 6       552/557
(99 %)
0 diff
(100 %id)
AI660663 colon, colonic mucosa from 5 ulcerative colitispatients .a 3674 to 4224 553 to 3       551/553
(99 %)
0 diff
(100 %id)
BE045445 carcinoid, lung .a 3674 to 4020 1 to 347     Submitted on the opposite strand 347/347
(100 %)
1 diff
(99.8 %id)
AW197001 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 3677 to 4224 548 to 1       548/548
(100 %)
1 diff
(99.9 %id)
BQ016063 lung, Metastatic Chondrosarcoma .a 3678 to 4223 564 to 19   AAA   546/547
(99 %)
16 diff
(97.1 %id)
CF528452 placenta .a 3685 to 4223 556 to 18   AAA   539/539
(100 %)
0 diff
(100 %id)
BE677046 dorsal root ganglia .a 3686 to 4224 541 to 3       539/541
(99 %)
0 diff
(100 %id)
CA406554 adipose .a 3697 to 3963 1 to 268       268/269
(99 %)
12 diff
(95.6 %id)
AW085722 esophagus, squamous cell carcinoma .a 3712 to 4224 517 to 5       513/517
(99 %)
0 diff
(100 %id)
TI_154133840   .a 3716 to 4223 604 to 95   AAA   510/1090
(46 %)
27 diff
(97.6 %id)
CA943497 Pancreas, Purified pancreatic islet .a 3734 to 4226 495 to 3       493/573
(86 %)
0 diff
(100 %id)
AI147299 brain, glioblastoma (pooled) .a 3745 to 4034 290 to 1       290/290
(100 %)
4 diff
(98.7 %id)
AI803680 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3751 to 4224 475 to 2       474/475
(99 %)
0 diff
(100 %id)
N40206 multiple sclerosis lesions .a 3755 to 4223 474 to 1       474/478
(99 %)
8 diff
(98.4 %id)
TI_154134174   .a 3755 to 4223 574 to 103   AAA   472/1246
(37 %)
19 diff
(98.5 %id)
AI804290 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3757 to 4223 467 to 1       467/467
(100 %)
2 diff
(99.6 %id)
AI420681 brain, glioblastoma (pooled) .a 3763 to 4219 456 to 1       456/456
(100 %)
7 diff
(98.5 %id)
AI147300 brain, glioblastoma (pooled) .a 3768 to 4224 465 to 8       458/465
(98 %)
0 diff
(100 %id)
AI093493 uterus .a 3781 to 4223 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AI889272 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3782 to 4223 456 to 15   AAA   442/442
(100 %)
4 diff
(99.1 %id)
AW337807 lymph node, lymphoma, follicular mixed small and largecell .a 3782 to 4223 453 to 12   AAA   442/442
(100 %)
1 diff
(99.8 %id)
BF477614 Prostate .a 3782 to 4224 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AA968897 Kidney, kidney tumor .a 3786 to 4178 393 to 1       393/393
(100 %)
1 diff
(99.8 %id)
AA991360 breast .a 3788 to 4224 440 to 4       437/440
(99 %)
0 diff
(100 %id)
AW082045 esophagus, squamous cell carcinoma .a 3788 to 4224 442 to 5       438/442
(99 %)
0 diff
(100 %id)
AW057624 pooled .a 3793 to 4223 443 to 13   AAA   431/431
(100 %)
1 diff
(99.8 %id)
AI522253 Kidney .a 3801 to 4224 428 to 4       425/428
(99 %)
0 diff
(100 %id)
AA810574 germinal center B cell .a 3802 to 4223 436 to 15   AAA   422/422
(100 %)
1 diff
(99.8 %id)
AI273564 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3802 to 4224 429 to 7       423/429
(98 %)
0 diff
(100 %id)
AI025636 parathyroid gland, parathyroid tumor .a 3804 to 4224 428 to 8       421/428
(98 %)
0 diff
(100 %id)
D61781   .a 3811 to 4153 1 to 343       343/343
(100 %)
1 diff
(99.8 %id)
N68219 cochlea, ear .a 3811 to 4223 424 to 12   AAA   413/413
(100 %)
1 diff
(99.8 %id)
AA743267 germinal center B cell .a 3816 to 4223 427 to 20   AAA   408/408
(100 %)
1 diff
(99.8 %id)
AW085282 pooled .a 3821 to 4224 418 to 7       412/418
(98 %)
0 diff
(100 %id)
AW196348 pooled germ cell tumors .a 3821 to 4224 404 to 1       404/404
(100 %)
1 diff
(99.8 %id)
BE242582 leukopheresis .a 3828 to 4221 396 to 3       394/396
(99 %)
0 diff
(100 %id)
AW474068 lymph node, lymphoma, follicular mixed small and largecell .a 3840 to 4224 386 to 2       385/386
(99 %)
0 diff
(100 %id)
N67596 cochlea, ear .a 3846 to 4224 391 to 6       386/393
(98 %)
0 diff
(100 %id)
AA599204 bone marrow stroma .a 3849 to 4223 391 to 17   AAA   375/375
(100 %)
1 diff
(99.8 %id)
AI818066 lymph node, lymphoma, follicular mixed small and largecell .a 3852 to 4224 376 to 4       373/376
(99 %)
0 diff
(100 %id)
AA599214 bone marrow stroma .a 3854 to 4223 394 to 25   AAA   370/370
(100 %)
0 diff
(100 %id)
AA283699 germinal center B cell .a 3855 to 4229 375 to 1   fully sequenced,   375/375
(100 %)
5 diff
(98.7 %id)
AI708918 aorta .a 3864 to 4223 360 to 1       360/360
(100 %)
7 diff
(98.1 %id)
BP397111 pancreatic islet .a 3865 to 4224 1 to 360     Submitted on the opposite strand 360/361
(99 %)
3 diff
(99.2 %id)
AI080452 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3865 to 4224 361 to 2       360/361
(99 %)
0 diff
(100 %id)
N52167 multiple sclerosis lesions .a 3866 to 4223 359 to 1       359/359
(100 %)
10 diff
(97.3 %id)
AI279907 adenocarcinoma, Pancreas .a 3880 to 4223 366 to 24   AAA   343/343
(100 %)
6 diff
(98.3 %id)
AA382105   .a 3882 to 4223 343 to 1       343/344
(99 %)
2 diff
(99.5 %id)
BU726538 eye, RPE and Choroid .a 3886 to 4223 355 to 18   AAA   338/338
(100 %)
3 diff
(99.2 %id)
AI202537 Prostate .a 3887 to 4223 337 to 1       337/337
(100 %)
1 diff
(99.8 %id)
AA991456 breast .a 3892 to 4224 341 to 9       333/341
(97 %)
0 diff
(100 %id)
AI474246 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3902 to 4223 325 to 1       325/325
(100 %)
3 diff
(99.1 %id)
AA757816 pineal gland .a 3903 to 4219 317 to 1       317/317
(100 %)
1 diff
(99.7 %id)
AI492753 lymph node, lymphoma, follicular mixed small and largecell .a 3903 to 4224 323 to 2       322/323
(99 %)
0 diff
(100 %id)
FN070397 breast carcinoma .a 3910 to 3985 76 to 1     Submitted on the opposite strand 76/77
(98 %)
0 diff
(100 %id)
AA903457 leiomyosarcoma, soft tissue .a 3910 to 4225 338 to 23   AAA   316/316
(100 %)
1 diff
(99.7 %id)
BU565154 mixed (pool of 40 RNAs) .a 3943 to 4223 1 to 281   AAA   281/281
(100 %)
3 diff
(99.0 %id)
AW198014 adenocarcinoma, Pancreas .a 3946 to 4223 308 to 31   AAA   278/278
(100 %)
10 diff
(96.5 %id)
AI916745 Kidney .a 3950 to 4223 285 to 12       274/285
(96 %)
0 diff
(100 %id)
BF436934 Prostate .a 3950 to 4224 280 to 6       275/280
(98 %)
0 diff
(100 %id)
AA321079 adipose tissue, white .a 3956 to 4223 268 to 1     Submitted on the opposite strand 268/275
(97 %)
2 diff
(99.3 %id)
AA099606 uterus .a 3974 to 4224 253 to 3       251/253
(99 %)
0 diff
(100 %id)
GD139204   .a 3975 to 4030 60 to 5     Submitted on the opposite strand 56/63
(88 %)
0 diff
(100 %id)
N62307 multiple sclerosis lesions .a 3985 to 4223 240 to 1       240/240
(100 %)
2 diff
(99.2 %id)
D79256 aorta .a 3991 to 4223 1 to 233       233/233
(100 %)
1 diff
(99.6 %id)
D79694 aorta .a 3991 to 4223 1 to 232       232/232
(100 %)
2 diff
(99.2 %id)
AI744127 Prostate .a 4012 to 4224 215 to 3       213/215
(99 %)
0 diff
(100 %id)
AI984299 Prostate .a 4012 to 4224 215 to 3       213/215
(99 %)
0 diff
(100 %id)
BE673231 Prostate .a 4012 to 4224 215 to 3       213/215
(99 %)
0 diff
(100 %id)
BF589706 Prostate .a 4012 to 4224 215 to 3       213/215
(99 %)
0 diff
(100 %id)
BF438322 Prostate .a 4012 to 4224 213 to 2       212/213
(99 %)
0 diff
(100 %id)
R27042 placenta .a 4017 to 4224 210 to 2       209/294
(71 %)
0 diff
(100 %id)
AW206497   .a 4037 to 4215 8 to 186     Submitted on the opposite strand 179/196
(91 %)
6 diff
(97.0 %id)
BM151254 leukopheresis .a 4058 to 4224 184 to 19       166/184
(90 %)
0 diff
(100 %id)
H89086 cochlea, ear .a 4091 to 4205 1 to 115       115/115
(100 %)
0 diff
(100 %id)
DA985587 synovial membrane tissue from rheumatioidarthritis .b 1 to 2079 2 to 550   tiling clone, capped Suspected internal deletion 544/549
(99 %)
0 diff
(100 %id)
CF138062 lymph .b 13 to 392 1 to 380       380/380
(100 %)
5 diff
(98.7 %id)
TI_154167808   .b 20 to 530 80 to 588       509/511
(99 %)
8 diff
(98.5 %id)
AW504365 lymph .b 22 to 553 1 to 532       532/532
(100 %)
4 diff
(99.3 %id)
TI_154160547   .b 28 to 749 89 to 798   tiling clone,   710/711
(99 %)
29 diff
(96.0 %id)
AW576401 lymph .b 4167 to 4577 428 to 18   tiling clone, AAA   411/411
(100 %)
7 diff
(98.3 %id)
CR607172 B cells (Ramos cell line) Cot 25-normalized .c 1 to 2180 1 to 2180 exact tiling clone,   2180/2180
(100 %)
0 diff
(100 %id)
BX385500   .c 1 to 1027 1 to 1019       1019/1019
(100 %)
20 diff
(98.1 %id)
BE247572 leukopheresis .c 92 to 383 1 to 292       292/292
(100 %)
7 diff
(97.7 %id)
DB106869.
matches multiple genes
thymus .c 94 to 908 2 to 503   capped also hits gene KIAA1147 457/557
(82 %)
13 diff
(97.7 %id)
AW500186 lymph .c 98 to 513 1 to 416       416/416
(100 %)
4 diff
(99.1 %id)
TI_57237937   .c 104 to 522 30 to 444       417/784
(53 %)
19 diff
(97.6 %id)
BI906463 leukocyte .c 105 to 436 1 to 341       338/392
(86 %)
20 diff
(94.9 %id)
BI909803 leukocyte .c 105 to 522 1 to 414       416/754
(55 %)
13 diff
(98.3 %id)
TI_154154289   .c 105 to 577 80 to 553       474/662
(71 %)
13 diff
(98.1 %id)
BQ879945 dorsal root ganglia .c 106 to 871 1 to 780       780/964
(80 %)
32 diff
(96.7 %id)
BF795641 lymph, lymphoma, cell line .c 111 to 528 29 to 452       424/452
(93 %)
20 diff
(95.6 %id)
DC301605   .c 124 to 678 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BI855997 breast, mammary adenocarcinoma, cell line .c 125 to 547 1 to 430       430/430
(100 %)
15 diff
(96.6 %id)
TI_57186474   .c 125 to 547 54 to 483       430/430
(100 %)
15 diff
(96.6 %id)
BM149287 leukopheresis .c 145 to 494 1 to 350       350/354
(98 %)
19 diff
(94.7 %id)
TI_57199079   .c 149 to 905 70 to 839       770/839
(91 %)
40 diff
(95.3 %id)
BI822248 pooled brain, lung, testis .c 150 to 905 1 to 769       769/769
(100 %)
34 diff
(95.6 %id)
BQ228722 embryonal carcinoma, cell line, testis .c 153 to 946 1 to 808       808/915
(88 %)
35 diff
(96.2 %id)
BG392514 embryonal carcinoma, cell line, testis .c 163 to 482 1 to 326       323/326
(99 %)
18 diff
(94.5 %id)
BQ431556 melanotic melanoma, skin .c 164 to 689 1 to 527       527/895
(58 %)
6 diff
(99.4 %id)
BP304127   .c 164 to 586 1 to 424       424/566
(74 %)
8 diff
(98.6 %id)
DA433332 cord Blood .c 170 to 593 8 to 431   capped   424/429
(98 %)
2 diff
(99.6 %id)
BE893446 melanotic melanoma, skin .c 196 to 689 1 to 497       497/945
(52 %)
22 diff
(97.7 %id)
CF135492 lymph .c 265 to 456 1 to 192       192/192
(100 %)
3 diff
(98.5 %id)
AW576242 lymph .c 3994 to 4266 290 to 18   tiling clone, AAA   273/273
(100 %)
2 diff
(99.3 %id)
AF031588   .d 1 to 1681 10 to 1690 P198L S303P S304H Q305R A306P ... tiling clone,   1682/1696
(99 %)
15 diff
(99.2 %id)
NM_003387.4   .d 1 to 4583 2 to 4584 exact RefSeq, AAA   4584/4584
(100 %)
4 diff
(100.0 %id)
BM153022 leukopheresis .d 13 to 521 1 to 509   tiling clone,   509/510
(99 %)
2 diff
(99.7 %id)
BE247610 leukopheresis .d 13 to 214 1 to 202       202/206
(98 %)
8 diff
(96.2 %id)
BM459256 lymph, lymphoma, cell line .d 17 to 671 1 to 667       667/1266
(52 %)
23 diff
(98.2 %id)
DA939780 Spleen .d 20 to 561 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
BU153533 embryonal carcinoma, cell line, testis .d 24 to 629 1 to 616       616/949
(64 %)
28 diff
(97.1 %id)
TI_1540412936   .e 1 to 338 338 to 3       336/453
(74 %)
3 diff
(99.4 %id)
DC300190   .e 3 to 588 1 to 586   tiling clone,   586/586
(100 %)
1 diff
(99.9 %id)
CN276424 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 14 to 479 1 to 468       468/468
(100 %)
9 diff
(98.1 %id)
NM_001077269.1   .e 28 to 4675 1 to 4648 exact RefSeq, AAA   4648/4648
(100 %)
4 diff
(100.0 %id)
BE242296 leukopheresis .e 43 to 333 1 to 291       291/291
(100 %)
2 diff
(99.4 %id)
BP231360 muscle .e 44 to 621 1 to 578       578/582
(99 %)
2 diff
(99.7 %id)
CR979604 T-Lymphocytes .e 44 to 795 1 to 752       752/756
(99 %)
5 diff
(99.4 %id)
BP349738 brain .e 44 to 622 1 to 579       579/583
(99 %)
1 diff
(99.9 %id)
BI760875 pooled colon, kidney, stomach .e 56 to 531 1 to 478       478/478
(100 %)
7 diff
(98.6 %id)
TI_57146925   .e 56 to 531 36 to 513       478/513
(93 %)
13 diff
(97.5 %id)
CR618785 Neuroblastoma Cot 50-normalized .e 60 to 2046 1 to 1987 exact tiling clone,   1987/1987
(100 %)
0 diff
(100 %id)
AL529597 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 60 to 1028 1 to 968   fully sequenced,   968/968
(100 %)
6 diff
(99.4 %id)
CN276422 embryonic stem cells, cell lines H1, H7, andH9 .e 104 to 549 1 to 446       446/447
(99 %)
0 diff
(100 %id)
BU429513 lymph .e 148 to 623 1 to 478       478/478
(100 %)
8 diff
(98.4 %id)
CR998982 T-Lymphocytes .e 152 to 716 43 to 604       563/604
(93 %)
10 diff
(98.4 %id)
TI_154150659   .e 155 to 886 79 to 811       733/802
(91 %)
43 diff
(94.7 %id)
BQ441937 embryonal carcinoma, cell line, testis .e 291 to 1086 1 to 815       815/865
(94 %)
30 diff
(96.6 %id)
BG106699 lymph, lymphoma, cell line .e 295 to 868 80 to 649       570/952
(59 %)
21 diff
(97.8 %id)
CF136621 lymph .e 377 to 492 1 to 116       116/116
(100 %)
5 diff
(95.7 %id)
BM456013 lymph, lymphoma, cell line .e 406 to 1112 1 to 723       723/1265
(57 %)
35 diff
(97.3 %id)
BG477050 melanotic melanoma, skin .e 429 to 873 1 to 446       446/843
(52 %)
13 diff
(98.5 %id)
AW403375 lymph .e 454 to 756 116 to 418       303/420
(72 %)
8 diff
(98.1 %id)
TI_154140018   .e 454 to 945 192 to 684       493/612
(80 %)
39 diff
(93.7 %id)
CF137988 lymph .e 467 to 1054 1 to 588       588/588
(100 %)
7 diff
(98.9 %id)
CR995862 T-Lymphocytes .e 471 to 1196 1 to 728       728/734
(99 %)
5 diff
(99.4 %id)
TI_154167697   .e 472 to 1124 78 to 734       657/827
(79 %)
10 diff
(98.8 %id)
BQ056834 lymph, lymphoma, cell line .e 483 to 1319 1 to 846       846/1011
(83 %)
22 diff
(97.9 %id)
BQ643022 lymph, lymphoma, cell line .e 483 to 1321 1 to 845       845/941
(89 %)
22 diff
(97.7 %id)
BG254409 adenocarcinoma, cell line, Prostate .e 495 to 815 1 to 326       326/1308
(24 %)
9 diff
(99.4 %id)
BU195245 melanotic melanoma, skin .e 510 to 1246 48 to 787       740/899
(82 %)
22 diff
(97.6 %id)
BU182677 melanotic melanoma, skin .e 535 to 1060 1 to 532       532/1099
(48 %)
10 diff
(99.1 %id)
BF975958 B-cells, primary B-cells from tonsils (cell line) .e 549 to 1095 7 to 552       546/552
(98 %)
12 diff
(97.9 %id)
BG756779 B-cells, primary B-cells from tonsils (cell line) .e 549 to 1287 7 to 746       740/746
(99 %)
7 diff
(99.1 %id)
BG758832 B-cells, primary B-cells from tonsils (cell line) .e 549 to 1281 7 to 759       753/763
(98 %)
41 diff
(94.7 %id)
BG756724 B-cells, primary B-cells from tonsils (cell line) .e 549 to 1258 7 to 714       708/714
(99 %)
7 diff
(99.1 %id)
BQ220315 embryonal carcinoma, cell line, testis .e 560 to 1422 1 to 862       862/862
(100 %)
13 diff
(98.5 %id)
BX370754   .e 575 to 1513 1 to 932       932/932
(100 %)
18 diff
(98.1 %id)
BU183661 melanotic melanoma, skin .e 598 to 1309 1 to 718       718/931
(77 %)
14 diff
(98.5 %id)
BU558263 adenocarcinoma, cell line, breast .e 620 to 1282 80 to 753       674/1038
(64 %)
6 diff
(99.5 %id)
BU860387 adenocarcinoma, cell line, breast .e 623 to 1409 1 to 798       798/897
(88 %)
18 diff
(98.0 %id)
BM465019 lymph, lymphoma, cell line .e 642 to 1321 1 to 683       683/1178
(57 %)
8 diff
(99.4 %id)
AI523615 B-cell, chronic lymphotic leukemia .e 659 to 1194 541 to 7       535/588
(90 %)
0 diff
(100 %id)
BY996167   .e 660 to 1310 16 to 666       651/666
(97 %)
6 diff
(99.1 %id)
CF136214 lymph .e 705 to 1086 1 to 382       382/382
(100 %)
7 diff
(98.2 %id)
AW172582 pooled .e 707 to 1057 351 to 1       351/416
(84 %)
10 diff
(97.6 %id)
TI_154165166   .e 712 to 1202 80 to 569       490/491
(99 %)
18 diff
(96.4 %id)
BQ052872 blood, natural killer cells, cell line .e 718 to 1532 1 to 818       818/998
(81 %)
22 diff
(97.8 %id)
BQ053487 blood, natural killer cells, cell line .e 718 to 1532 1 to 823       823/1073
(76 %)
18 diff
(98.4 %id)
BQ356004 head_neck .e 730 to 1188 21 to 477       457/477
(95 %)
6 diff
(98.8 %id)
DA234461 brain .e 739 to 1312 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
CF136049 lymph .e 747 to 1042 8 to 303       296/304
(97 %)
4 diff
(98.7 %id)
TI_154164857   .e 747 to 1487 76 to 809       734/917
(80 %)
48 diff
(94.8 %id)
BQ356150 head_neck .e 754 to 1125 39 to 407       369/407
(90 %)
6 diff
(98.6 %id)
AF106062   .e 763 to 2069 1 to 1306       1306/1306
(100 %)
3 diff
(99.8 %id)
CF143905 lymph .e 784 to 1187 1 to 404       404/404
(100 %)
6 diff
(98.6 %id)
BU429319 lymph .e 787 to 1131 8 to 352       345/352
(98 %)
6 diff
(98.3 %id)
TI_154150301   .e 787 to 1539 80 to 832       753/755
(99 %)
47 diff
(93.8 %id)
TI_154175576   .e 791 to 1207 80 to 496       417/417
(100 %)
2 diff
(99.6 %id)
BQ335124 marrow .e 796 to 1101 11 to 315       305/315
(96 %)
6 diff
(98.1 %id)
CF136722 lymph .e 823 to 1269 8 to 454       447/457
(97 %)
2 diff
(99.6 %id)
TI_154165876   .e 823 to 1293 80 to 549       470/470
(100 %)
2 diff
(99.6 %id)
BG176774 lymph, lymphoma, cell line .e 851 to 1274 1 to 427       427/923
(46 %)
5 diff
(99.5 %id)
BU429594 lymph .e 863 to 1439 1 to 577       577/577
(100 %)
5 diff
(99.2 %id)
BI022266 marrow .e 865 to 1270 423 to 13       411/423
(97 %)
0 diff
(100 %id)
TI_154150711   .e 870 to 1650 80 to 855       776/792
(97 %)
13 diff
(98.4 %id)
BI025746 marrow .e 883 to 1270 414 to 29       386/414
(93 %)
0 diff
(100 %id)
BE676790 B-cell, chronic lymphotic leukemia .e 951 to 1194 250 to 7       244/250
(97 %)
0 diff
(100 %id)
BE831674 marrow .e 987 to 1404 412 to 1       412/412
(100 %)
10 diff
(97.6 %id)
BY994395   .e 997 to 1605 10 to 618       609/618
(98 %)
0 diff
(100 %id)
AL529596 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 998 to 2046 1040 to 1   fully sequenced,   1040/1040
(100 %)
25 diff
(97.6 %id)
BX385499   .e 1023 to 2039 1009 to 1       1009/1009
(100 %)
22 diff
(97.9 %id)
CN276426 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 1031 to 1635 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
CN276425 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1065 to 1599 1 to 535       535/535
(100 %)
2 diff
(99.7 %id)
BU146351 dorsal root ganglia .e 1095 to 1648 1 to 558       558/800
(69 %)
10 diff
(98.8 %id)
CR987439 T-Lymphocytes .e 1104 to 1970 1 to 867       867/872
(99 %)
1 diff
(99.9 %id)
AA767645 germinal center B cell .e 1136 to 1573 439 to 1       439/449
(97 %)
1 diff
(99.8 %id)
CF137015 lymph .e 1139 to 1456 1 to 318       318/318
(100 %)
4 diff
(98.8 %id)
TI_154166330   .e 1145 to 1611 79 to 547       469/1037
(45 %)
4 diff
(99.7 %id)
AW500363 lymph .e 1178 to 1674 8 to 504       497/504
(98 %)
11 diff
(97.9 %id)
TI_154154551   .e 1178 to 1828 80 to 728       649/652
(99 %)
24 diff
(96.4 %id)
BU428708 lymph .e 1184 to 1646 8 to 470       463/470
(98 %)
6 diff
(98.8 %id)
BU428714 lymph .e 1184 to 1606 8 to 430       423/430
(98 %)
7 diff
(98.4 %id)
TI_154149515   .e 1184 to 1683 79 to 579       501/501
(100 %)
5 diff
(99.1 %id)
TI_154149557   .e 1184 to 1686 78 to 580       503/503
(100 %)
0 diff
(100 %id)
BU428771 lymph .e 1194 to 1597 1 to 404       404/404
(100 %)
4 diff
(99.1 %id)
BU178762 melanotic melanoma, skin .e 1194 to 1988 12 to 806       795/806
(98 %)
6 diff
(99.3 %id)
TI_154149598   .e 1201 to 1720 79 to 601       523/525
(99 %)
16 diff
(97.0 %id)
CR622538 Placenta Cot 25-normalized .e 1238 to 2069 1 to 832       832/832
(100 %)
0 diff
(100 %id)
BX339439 Placenta Cot 25-normalized .e 1239 to 2069 1 to 831   fully sequenced,   831/831
(100 %)
6 diff
(99.3 %id)
BI036487 nervous_tumor .e 1253 to 1415 1 to 163       163/164
(99 %)
6 diff
(96.4 %id)
BU429356 lymph .e 1263 to 1646 8 to 391       384/391
(98 %)
6 diff
(98.5 %id)
AW505300 lymph .e 1263 to 1699 8 to 444       437/444
(98 %)
6 diff
(98.7 %id)
TI_154150374   .e 1263 to 1837 80 to 654       575/786
(73 %)
5 diff
(99.4 %id)
TI_154162032   .e 1263 to 1837 70 to 644       575/579
(99 %)
11 diff
(98.2 %id)
BQ232283 embryonal carcinoma, cell line, testis .e 1278 to 2131 4 to 874       878/880
(99 %)
27 diff
(97.0 %id)
ES313994 beard hair, skin .e 1280 to 1779 1 to 500       500/500
(100 %)
0 diff
(100 %id)
BF897924 marrow .e 1323 to 1702 14 to 393       380/405
(93 %)
8 diff
(98.1 %id)
W67344 heart .e 1325 to 1376 1 to 52       52/52
(100 %)
0 diff
(100 %id)
BF897618 marrow .e 1329 to 1701 10 to 382       373/382
(97 %)
6 diff
(98.5 %id)
DB244939 uterus, tumor tissue .e 1344 to 1818 2 to 476   capped   475/475
(100 %)
0 diff
(100 %id)
AW503781 lymph .e 1349 to 1620 1 to 272       272/272
(100 %)
5 diff
(98.2 %id)
AW503791 lymph .e 1349 to 1781 1 to 433       433/433
(100 %)
4 diff
(99.1 %id)
CF135705 lymph .e 1354 to 1965 1 to 612       612/612
(100 %)
8 diff
(98.7 %id)
TI_154159792   .e 1356 to 1834 89 to 568       480/487
(98 %)
27 diff
(94.5 %id)
TI_154159798   .e 1356 to 1834 85 to 563       479/486
(98 %)
5 diff
(99.0 %id)
TI_154164227   .e 1360 to 2162 69 to 865       797/890
(89 %)
24 diff
(97.4 %id)
BU428795 lymph .e 1369 to 1826 8 to 465       458/465
(98 %)
6 diff
(98.8 %id)
TI_154149616   .e 1369 to 1837 67 to 535       469/525
(89 %)
5 diff
(99.1 %id)
CA430199 cell lines, Chondrosarcoma .e 1389 to 2069 699 to 19   AAA   681/681
(100 %)
0 diff
(100 %id)
BG255532 adenocarcinoma, cell line, Prostate .e 1406 to 2144 1 to 745       745/1019
(73 %)
32 diff
(96.9 %id)
CR989460 T-Lymphocytes .e 1413 to 2222 1 to 811       811/811
(100 %)
1 diff
(99.9 %id)
AW501637 lymph .e 1420 to 1824 1 to 405       405/405
(100 %)
4 diff
(99.1 %id)
TI_154156708   .e 1426 to 1861 79 to 514       436/508
(85 %)
8 diff
(98.5 %id)
BM542331 melanotic melanoma, skin .e 1430 to 2130 1 to 704       704/987
(71 %)
7 diff
(99.3 %id)
CN276427 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 1435 to 2142 1 to 708       708/708
(100 %)
1 diff
(99.9 %id)
CN276423 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1437 to 2086 1 to 652       654/656
(99 %)
9 diff
(98.7 %id)
TI_154159444   .e 1448 to 1825 461 to 84     Submitted on the opposite strand 378/465
(81 %)
5 diff
(99.0 %id)
TI_154132165   .e 1458 to 2069 722 to 109   AAA   614/776
(79 %)
9 diff
(98.9 %id)
AW503529 lymph .e 1476 to 1832 357 to 1     Submitted on the opposite strand 357/357
(100 %)
4 diff
(98.9 %id)
BP428653   .e 1483 to 1878 1 to 396       396/396
(100 %)
3 diff
(99.3 %id)
CD368449 Alveolar Macrophage, lung .e 1483 to 2060 604 to 27   AAA   578/586
(98 %)
2 diff
(99.7 %id)
CR621647 Placenta Cot 25-normalized .e 1491 to 2090 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BX396854 Placenta Cot 25-normalized .e 1491 to 2090 1 to 602   fully sequenced,   602/602
(100 %)
3 diff
(99.6 %id)
DA992068 synovial membrane tissue from rheumatioidarthritis .e 1504 to 2067 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA383882 thalamus .e 1507 to 2054 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
AI394409 pooled .e 1515 to 2066 563 to 15   AAA   549/549
(100 %)
16 diff
(97.1 %id)
AA811088 germinal center B cell .e 1532 to 2063 552 to 20       533/571
(93 %)
8 diff
(98.6 %id)
AW977786   .e 1543 to 2068 525 to 1     Submitted on the opposite strand 525/527
(99 %)
20 diff
(96.3 %id)
BE729703 melanotic melanoma, skin .e 1567 to 2312 1 to 742       742/953
(77 %)
15 diff
(98.5 %id)
AW574751 lymph .e 1572 to 2069 515 to 18   AAA   498/498
(100 %)
0 diff
(100 %id)
BX339438 Placenta Cot 25-normalized .e 1576 to 2007 432 to 1   fully sequenced,   432/432
(100 %)
2 diff
(99.6 %id)
AL134836 melanoma (MeWo cell line) .e 1581 to 2068 531 to 44   AAA Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
BF901264 marrow .e 1590 to 1763 178 to 4     Submitted on the opposite strand 175/178
(98 %)
0 diff
(100 %id)
BI018664 marrow .e 1590 to 1789 255 to 57       199/255
(78 %)
0 diff
(100 %id)
BI018670 marrow .e 1590 to 1797 255 to 49       207/255
(81 %)
5 diff
(98.1 %id)
BP384425 pancreatic islet .e 1591 to 2086 1 to 496     Submitted on the opposite strand 496/500
(99 %)
1 diff
(99.8 %id)
BP385753 pancreatic islet .e 1599 to 2043 1 to 447     Submitted on the opposite strand 447/451
(99 %)
4 diff
(99.2 %id)
DA815642   .e 1656 to 2236 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
CR993145 T-Lymphocytes .e 1656 to 2428 1 to 775       775/781
(99 %)
3 diff
(99.7 %id)
AA811758 germinal center B cell .e 1661 to 2068 422 to 15   AAA   408/408
(100 %)
1 diff
(99.8 %id)
DA903643   .e 1662 to 2225 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AA811105 germinal center B cell .e 1678 to 2069 405 to 14   AAA   392/392
(100 %)
3 diff
(99.3 %id)
AW136073   .e 1680 to 2067 405 to 18   AAA   388/388
(100 %)
0 diff
(100 %id)
CT000875 T-Lymphocytes .e 1733 to 2477 1 to 745       745/745
(100 %)
1 diff
(99.9 %id)
AA632394 breast .e 1738 to 2079 348 to 7       342/348
(98 %)
0 diff
(100 %id)
BX396853 Placenta Cot 25-normalized .e 1747 to 2052 307 to 1   fully sequenced,   307/307
(100 %)
4 diff
(98.7 %id)
AI270255 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1854 to 2070 217 to 1       217/217
(100 %)
0 diff
(100 %id)
AA926898 pooled .e 1931 to 2071 141 to 1       141/141
(100 %)
0 diff
(100 %id)
BG106368 lymph, lymphoma, cell line .e 1942 to 2730 1 to 789       789/873
(90 %)
33 diff
(96.3 %id)
BF692537 melanotic melanoma, high MDR, skin .e 1956 to 2631 1 to 666       666/867
(76 %)
25 diff
(97.2 %id)
BU941809 mixed (pool of 40 RNAs) .e 1962 to 2701 1 to 745       745/789
(94 %)
26 diff
(96.8 %id)
AL832275 lymph node .e 2024 to 4674 1 to 2651   tiling clone, available from DKFZ, AAA   2651/2651
(100 %)
7 diff
(99.8 %id)
AA357858 lung .e 2067 to 2435 10 to 383       374/386
(96 %)
10 diff
(97.5 %id)
DA674733   .e 2083 to 2664 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
AW504914 lymph .e 2119 to 2631 8 to 520       513/520
(98 %)
6 diff
(98.9 %id)
TI_154161325   .e 2119 to 2684 66 to 631       566/566
(100 %)
3 diff
(99.5 %id)
AW771053 colon, juvenile granulosa tumor .e 2120 to 2525 406 to 1       406/406
(100 %)
0 diff
(100 %id)
BQ720671 sympathetic trunk .e 2158 to 3021 1 to 866       866/867
(99 %)
13 diff
(98.6 %id)
BX956482   .e 2160 to 2527 1 to 368       368/368
(100 %)
1 diff
(99.8 %id)
BX415650 thymus .e 2167 to 3030 1 to 867       867/867
(100 %)
6 diff
(99.4 %id)
BG388536 embryonal carcinoma, cell line, testis .e 2185 to 2933 1 to 739       739/743
(99 %)
26 diff
(96.6 %id)
BG024528 lymph, lymphoma, cell line .e 2200 to 2909 1 to 714       714/768
(92 %)
26 diff
(96.7 %id)
AW407609 lymph .e 2217 to 2448 7 to 238       232/238
(97 %)
6 diff
(97.5 %id)
TI_154146142   .e 2217 to 2925 79 to 793   tiling clone,   715/822
(86 %)
52 diff
(93.7 %id)
TI_154147198   .e 2217 to 2848 81 to 710       630/631
(99 %)
24 diff
(96.2 %id)
AA361308   .e 2246 to 2494 1 to 249       249/249
(100 %)
1 diff
(99.6 %id)
DA286785 corpus callosum .e 2257 to 2816 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA749154   .e 2258 to 2841 2 to 585   capped   584/584
(100 %)
4 diff
(99.4 %id)
AW955427   .e 2263 to 2966 1 to 712       712/716
(99 %)
17 diff
(97.7 %id)
DA828919 placenta .e 2270 to 3044 2 to 790   capped   789/849
(92 %)
23 diff
(97.3 %id)
BY997021   .e 2281 to 2822 24 to 565       542/565
(95 %)
6 diff
(99.0 %id)
DA656682   .e 2284 to 2860 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
CD638994 pooled .e 2307 to 2989 1 to 680       680/732
(92 %)
10 diff
(98.7 %id)
AA765228 germinal center B cell .e 2320 to 2747 438 to 12   AAA   427/427
(100 %)
3 diff
(99.3 %id)
DA136242 alzheimer cortex .e 2332 to 2961 2 to 633   capped   632/632
(100 %)
7 diff
(98.9 %id)
DA374337 thalamus .e 2334 to 2650 2 to 318   capped   317/317
(100 %)
1 diff
(99.7 %id)
R36821   .e 2347 to 2520 1 to 176       176/177
(99 %)
3 diff
(98.4 %id)
TI_227712481   .e 2353 to 3367 1066 to 61   AAA   1006/1044
(96 %)
25 diff
(97.7 %id)
AI299312 carcinoid, lung .e 2390 to 2747 382 to 25   AAA   358/358
(100 %)
5 diff
(98.7 %id)
BX415649 thymus .e 3709 to 4659 951 to 1       951/951
(100 %)
3 diff
(99.7 %id)
AW576392 lymph .e 4182 to 4675 511 to 18   tiling clone, AAA   494/494
(100 %)
4 diff
(99.2 %id)
DB373543 placenta .e 4236 to 4675 444 to 1       444/445
(99 %)
9 diff
(98.0 %id)
AW576170 lymph .e 4376 to 4675 317 to 18   AAA   300/300
(100 %)
5 diff
(98.4 %id)
AW576188 lymph .e 4456 to 4675 237 to 18   AAA   220/220
(100 %)
11 diff
(95.0 %id)
X86019 peripheral blood .f 1 to 2547 1 to 2550 P198L S303P S304H Q305R A306P ... tiling clone,   2550/2578
(98 %)
11 diff
(99.6 %id)
CO408444   .f 2264 to 2481 218 to 1     Submitted on the opposite strand 218/222
(98 %)
1 diff
(99.6 %id)
DV643944   .f 2264 to 2481 218 to 1     Submitted on the opposite strand 218/339
(64 %)
1 diff
(99.8 %id)
BX346416   .g 1 to 893 1 to 890   tiling clone, fully sequenced,   890/890
(100 %)
22 diff
(97.6 %id)
BX346415   .g 863 to 1815 951 to 1   tiling clone, fully sequenced,   951/951
(100 %)
27 diff
(97.2 %id)
BC110288 Colon, Kidney, Stomach, adult, whole pooled .h 1 to 1772 1 to 1772 P198L tiling clone, AAA   1772/1772
(100 %)
1 diff
(100.0 %id)
BQ429900 melanotic melanoma, skin .h 809 to 1697 1 to 899       899/901
(99 %)
33 diff
(96.4 %id)
BX387890   .h 881 to 1689 803 to 1       803/803
(100 %)
17 diff
(97.9 %id)
BF446719 carcinoid, lung .h 1070 to 1768 693 to 1       693/693
(100 %)
23 diff
(96.7 %id)
BX373943.
matches multiple genes
  .h 1250 to 1769 520 to 1     also hits gene TRIM27 520/538
(96 %)
30 diff
(94.5 %id)
AI569415 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h 1321 to 1772 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI916481 adenocarcinoma, Pancreas .h 1322 to 1772 452 to 4       449/452
(99 %)
0 diff
(100 %id)
AA767669 germinal center B cell .h 1341 to 1772 465 to 34   AAA   432/432
(100 %)
0 diff
(100 %id)
AA649132 germinal center B cell .h 1400 to 1715 316 to 1       316/316
(100 %)
5 diff
(98.5 %id)
AA394043 ovarian tumor, ovary .h 1444 to 1575 1 to 131   fully sequenced,   131/131
(100 %)
0 diff
(100 %id)
AA455802 ovarian tumor, ovary .h 1444 to 1760 1 to 317   fully sequenced,   317/317
(100 %)
0 diff
(100 %id)
BX097182 ovarian tumor, ovary .h 1445 to 1764 1 to 320   AAA   320/320
(100 %)
0 diff
(100 %id)
AA419190 ovarian tumor, ovary .h 1515 to 1578 1 to 65   fully sequenced,   65/65
(100 %)
0 diff
(100 %id)
T60640 lung .h 1530 to 1772 1 to 243       243/244
(99 %)
3 diff
(98.8 %id)
AA292758 ovarian tumor, ovary .h 1545 to 1770 226 to 1   fully sequenced,   226/226
(100 %)
0 diff
(100 %id)
AA419033 ovarian tumor, ovary .h 1548 to 1713 166 to 1   fully sequenced,   166/166
(100 %)
0 diff
(100 %id)
AA456622 ovarian tumor, ovary .h 1604 to 1770 167 to 1   fully sequenced,   167/167
(100 %)
0 diff
(100 %id)
AK304194 trachea .i 1 to 1580 1 to 1580 L36P P198L tiling clone,   1580/1580
(100 %)
5 diff
(99.7 %id)
DC416792 trachea .i 1 to 532 1 to 532       532/532
(100 %)
4 diff
(99.3 %id)
DC391959 Spleen .i 13 to 590 1 to 578   tiling clone,   578/578
(100 %)
2 diff
(99.7 %id)
DA857459 placenta .j 1 to 564 2 to 565   tiling clone, to resequence, capped   564/564
(100 %)
0 diff
(100 %id)
DB151596 thymus .j 174 to 736 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
AL706234 human skeletal muscle .j 370 to 1120 1 to 751   tiling clone,   751/751
(100 %)
0 diff
(100 %id)
BX106406 pooled .j 900 to 1456 1 to 557   tiling clone,   557/557
(100 %)
2 diff
(99.7 %id)
AA970831 pooled .j 1091 to 1460 370 to 1   tiling clone,   370/370
(100 %)
2 diff
(99.5 %id)
DB328934 placenta .j 2153 to 2697 545 to 1   tiling clone, to resequence,   545/545
(100 %)
1 diff
(99.9 %id)
AW402314 lymph .k 1 to 488 8 to 495       488/495
(98 %)
6 diff
(98.8 %id)
TI_154138657   .k 1 to 508 81 to 588 exact tiling clone,   508/508
(100 %)
0 diff
(100 %id)
BU153081 melanotic melanoma, skin .l 1 to 777 1 to 777 exact tiling clone, AAA   777/779
(99 %)
5 diff
(99.4 %id)
BQ709479 Spleen .m-u 1 to 638 12 to 651 G103S G108E G109E G110S G113E ... tiling clone,   640/816
(78 %)
6 diff
(99.3 %id)
BE142225 head_neck .m-u 49 to 373 1 to 334       334/334
(100 %)
26 diff
(92.3 %id)
AA025702 heart .n 1 to 173 1 to 172   tiling clone,   172/193
(89 %)
2 diff
(99.0 %id)
AA025558 heart .n 629 to 786 166 to 9   tiling clone,   158/166
(95 %)
0 diff
(100 %id)
H95693 pineal gland .o 1 to 300 1 to 303   tiling clone, Submitted on the opposite strand 303/303
(100 %)
3 diff
(99.1 %id)
W02322 melanocyte .o 129 to 526 1 to 399       399/399
(100 %)
8 diff
(98.0 %id)
AA228140 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 129 to 506 1 to 378   tiling clone,   378/378
(100 %)
0 diff
(100 %id)
AL599603   .o 254 to 830 1 to 577       577/577
(100 %)
0 diff
(100 %id)
H95692 pineal gland .o 390 to 680 293 to 1     Submitted on the opposite strand 293/293
(100 %)
3 diff
(99.0 %id)
DA961040 Spleen .o 433 to 981 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
CD706730 normal nasopharynx .o 437 to 953 40 to 556       517/556
(92 %)
6 diff
(99.0 %id)
N73094 melanocyte .o 1421 to 1893 475 to 1   tiling clone,   475/477
(99 %)
5 diff
(99.0 %id)
AA227976 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 1481 to 1894 414 to 1   tiling clone,   414/414
(100 %)
2 diff
(99.6 %id)
AA459777   .p 1 to 116 1 to 116 exact tiling clone,   116/116
(100 %)
0 diff
(100 %id)
AA459654   .p 1505 to 1800 298 to 1   tiling clone,   298/298
(100 %)
3 diff
(99.0 %id)
DA672087   .q 1 to 552 2 to 553 K65R tiling clone, capped   552/552
(100 %)
1 diff
(99.9 %id)
DB322271   .q 1264 to 1797 535 to 1   tiling clone,   535/535
(100 %)
1 diff
(99.9 %id)
AL598697   .r-u 1 to 624 1 to 624 exact tiling clone,   624/624
(100 %)
2 diff
(99.7 %id)
BI048567 testis_normal .r-u 361 to 550 1 to 184       184/186
(98 %)
12 diff
(93.6 %id)
BI048568 testis_normal .r-u 707 to 971 1 to 265   tiling clone,   265/274
(96 %)
10 diff
(96.4 %id)
BI906558 leukocyte .s 1 to 788 1 to 789 exact tiling clone,   789/789
(100 %)
3 diff
(99.7 %id)
TI_57232960   .s 1 to 788 29 to 817 exact     789/817
(96 %)
9 diff
(98.9 %id)
DA675666   .s 288 to 874 2 to 589 exact tiling clone, capped   588/588
(100 %)
2 diff
(99.7 %id)
DA670288   .t 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
2 diff
(99.7 %id)
TI_57232024   .t 27 to 639 30 to 641 exact     612/641
(95 %)
8 diff
(98.8 %id)
BI905901 leukocyte .t 28 to 639 1 to 611 exact tiling clone,   611/611
(100 %)
1 diff
(99.9 %id)
DA674627   .u 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
DA677330   .u 15 to 612 2 to 599   tiling clone, capped   598/598
(100 %)
0 diff
(100 %id)
DB144142 thymus .va-u 1 to 558 2 to 561 exact tiling clone, capped   560/560
(100 %)
2 diff
(99.7 %id)
AI216598 carcinoid, lung .va-u 376 to 505 1 to 130     Submitted on the opposite strand 130/130
(100 %)
4 diff
(97.0 %id)
AA610841 lung, lung tumor .vb-u 1 to 500 501 to 1 T2F tiling clone,   501/501
(100 %)
2 diff
(99.7 %id)
CD704245 normal nasopharynx .vc-u 1 to 413 37 to 449 exact tiling clone,   416/449
(92 %)
6 diff
(98.7 %id)
BF992143 placenta_normal .vd-u 1 to 314 3 to 316 A2S F3R tiling clone,   314/316
(99 %)
5 diff
(98.5 %id)
BF912116 uterus_tumor .ve-u 1 to 235 1 to 235 H2L G5S tiling clone,   235/235
(100 %)
9 diff
(96.2 %id)
BF912175 uterus_tumor .ve-u 5 to 235 1 to 231   tiling clone,   231/231
(100 %)
4 diff
(98.3 %id)
BF912124 uterus_tumor .ve-u 7 to 235 18 to 246       229/246
(93 %)
6 diff
(97.6 %id)
BF912128 uterus_tumor .ve-u 7 to 235 16 to 244   tiling clone,   229/244
(93 %)
6 diff
(97.6 %id)
BF912117 uterus_tumor .vf-u 1 to 134 1 to 134 S7C C13S F21L     134/147
(91 %)
4 diff
(97.3 %id)
BF912129 uterus_tumor .vf-u 1 to 134 1 to 134 S7C F21L     134/147
(91 %)
3 diff
(98.0 %id)
BF912176 uterus_tumor .vf-u 1 to 134 1 to 134 exact tiling clone,   134/154
(87 %)
1 diff
(99.4 %id)
CV329970 uterus_tumor .vf-u 1 to 134 1 to 134 S7C     134/147
(91 %)
2 diff
(98.7 %id)
AK301271 Spleen Gene WIPF1andRNU7-44P, variant not shown         Suspected internal deletion, this clone was ignored    
AW802498 uterus Gene WIPF1andRNU7-44P, variant not shown         Suspected internal deletion, this clone was ignored    
BC002914 Skin, melanotic melanoma. Gene WIPF1andRNU7-44P, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
DB296054 bladder Gene WIPF1andRNU7-44P, variant not shown              
DA043068 bladder Gene WIPF1andRNU7-44P, variant not shown       capped      
BX482533   Gene WIPF1andRNU7-44P, variant not shown         This clone was ignored    
BX482534   Gene WIPF1andRNU7-44P, variant not shown         This clone was ignored    
AW015842   Gene WIPF1andRNU7-44P, variant not shown       AAA This clone was ignored    
CF136628 lymph Gene WIPF1andRNU7-44P, variant not shown         Suspected internal deletion, this clone was ignored    
DB329063 placenta Gene WIPF1andRNU7-44P, variant not shown         Submitted on the opposite strand    
CR991568 T-Lymphocytes Gene WIPF1andRNU7-44P, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154165760   Gene WIPF1andRNU7-44P, variant not shown         Suspected internal deletion, this clone was ignored    
DB217435 trachea Gene WIPF1andRNU7-44P, variant not shown       capped This clone was ignored    
DB349185 trachea Gene WIPF1andRNU7-44P, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o, .p, .q, .r-u, .s, .t, .u, .va-u, .vb-u, .vc-u, .vd-u, .ve-u, .vf-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI